Clinical Trial Update: Risk-adapted Adjuvant Chemotherapy Guided by the Tumour Stage for Operated Pancreatic Adenocarcinoma Following Neoadjuvant Chemotherapy With mFOLFIRINOX [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating risk-adapted adjuvant chemotherapy guided by tumor stage after neoadjuvant mFOLFIRINOX in patients with resected pan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• mFOLFIRINOX

Snippet

Sponsor: University Hospital, Rouen | Conditions: Resected Pancreatic Adenocarcinoma | Phase 2, Phase 3 | Status: RECRUITING